• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes and antiplatelet therapy in acute coronary syndrome.

作者信息

Ferreiro José Luis, Angiolillo Dominick J

机构信息

University of Florida College of Medicine-Jacksonville, 655 W 8th St., Jacksonville, FL 32209, USA.

出版信息

Circulation. 2011 Feb 22;123(7):798-813. doi: 10.1161/CIRCULATIONAHA.109.913376.

DOI:10.1161/CIRCULATIONAHA.109.913376
PMID:21343595
Abstract
摘要

相似文献

1
Diabetes and antiplatelet therapy in acute coronary syndrome.急性冠状动脉综合征中的糖尿病与抗血小板治疗
Circulation. 2011 Feb 22;123(7):798-813. doi: 10.1161/CIRCULATIONAHA.109.913376.
2
Emerging insights on antiplatelet therapy. Introduction.抗血小板治疗的新见解。引言。
Am J Cardiol. 2009 Feb 2;103(3 Suppl):1A-3A. doi: 10.1016/j.amjcard.2008.11.015.
3
[Evaluation of platelet response to antiplatelet drugs. An important clue for cardiologists and cardiosurgeons].[血小板对抗血小板药物反应的评估。心脏病学家和心脏外科医生的重要线索]
Kardiol Pol. 2007 Oct;65(10):1266-9.
4
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.应对急性冠状动脉综合征合并糖尿病患者的血栓形成负担。
Expert Rev Cardiovasc Ther. 2011 Jun;9(6):697-710. doi: 10.1586/erc.11.76.
5
Novel antiplatelet therapy.新型抗血小板治疗。
Am Heart J. 2010 Oct;160(4):595-604. doi: 10.1016/j.ahj.2010.06.007.
6
Recent therapeutic approaches to platelet activation in coronary artery disease.近期冠心病血小板活化的治疗方法。
Pharmacol Ther. 2010 Aug;127(2):108-20. doi: 10.1016/j.pharmthera.2010.05.001. Epub 2010 May 28.
7
New directions in antiplatelet therapy.抗血小板治疗的新方向。
Circ Cardiovasc Interv. 2012 Jun;5(3):433-45. doi: 10.1161/CIRCINTERVENTIONS.111.966176.
8
Platelet monitoring for PCI: which test is the one to choose?经皮冠状动脉介入治疗（PCI）中的血小板监测：应该选择哪种检测方法？
Hamostaseologie. 2009 Nov;29(4):376-80.
9
[Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].[血小板糖蛋白IIb/IIIa受体阻滞剂在急性冠状动脉综合征患者治疗及经皮冠状动脉介入治疗中的应用]
Ter Arkh. 2009;81(1):84-7.
10
Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?急性冠状动脉综合征和经皮冠状动脉介入治疗患者的抗血小板治疗强度：普拉格雷的前景？
Cardiol Clin. 2008 Nov;26(4):629-37. doi: 10.1016/j.ccl.2008.07.003.

引用本文的文献

1
Integrated metabolic-inflammatory risk assessment: HbA1c/HDL-c and hsCRP-to-albumin ratios synergistically predict major adverse cardiovascular events in post-PCI STEMI patients.综合代谢-炎症风险评估：糖化血红蛋白/高密度脂蛋白胆固醇及高敏C反应蛋白与白蛋白比值协同预测经皮冠状动脉介入治疗后的ST段抬高型心肌梗死患者的主要不良心血管事件。
Lipids Health Dis. 2025 Sep 13;24(1):280. doi: 10.1186/s12944-025-02707-2.
2
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme.在高出血风险糖尿病患者中，依维莫司洗脱支架植入术后1个月与3个月双重抗血小板治疗对比：XIENCE短期双重抗血小板治疗项目结果
EuroIntervention. 2025 Jun 16;21(12):e668-e680. doi: 10.4244/EIJ-D-24-00897.
3
Dual antiplatelets therapy prescription trends and mortality outcomes among senior citizens with acute coronary syndrome: insights from the Malaysian National Cardiovascular Disease Database.
马来西亚国家心血管疾病数据库的见解：老年急性冠状动脉综合征患者的双联抗血小板治疗处方趋势及死亡率结果
J Geriatr Cardiol. 2025 Feb 28;22(2):237-245. doi: 10.26599/1671-5411.2025.02.004.
4
Real-time platelet P2Y receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy.实时血小板P2Y受体占有率作为一种有前景的药效学生物标志物，用于弥合氯吡格雷治疗的药代动力学/药效学之间的差距。
Acta Pharm Sin B. 2025 Jan;15(1):484-493. doi: 10.1016/j.apsb.2024.08.008. Epub 2024 Aug 13.
5
Comparison of 1-Year Clinical Outcomes Between Ticagrelor Versus Clopidogrel in Type 2 Diabetes Patients After Implantation of Small Diameter Stents.替格瑞洛与氯吡格雷在小直径支架植入术后2型糖尿病患者中1年临床结局的比较
Anatol J Cardiol. 2025 Jan 7;29(2):95-103. doi: 10.14744/AnatolJCardiol.2024.4603.
6
Clopidogrel-Mediated P2Y Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.糖尿病合并冠心病患者中氯吡格雷介导的P2Y抑制作用与肾功能的关系
JACC Basic Transl Sci. 2024 Mar 25;9(7):865-876. doi: 10.1016/j.jacbts.2024.03.003. eCollection 2024 Jul.
7
Acute Hyperglycemia-Induced Injury in Myocardial Infarction.急性高血糖诱导的心肌梗死损伤。
Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504.
8
Tailoring Antithrombotic Regimens for Percutaneous Coronary Intervention Patients with High Bleeding and Ischemic Risk (): Individualized Management and Genotype-Guided De-escalation.为具有高出血和缺血风险的经皮冠状动脉介入治疗患者量身定制抗血栓治疗方案（ ）：个体化管理与基因分型指导的降阶梯治疗
Rev Cardiovasc Med. 2023 Dec 12;24(12):348. doi: 10.31083/j.rcm2412348. eCollection 2023 Dec.
9
Depression Following Acute Coronary Syndrome: A Review.急性冠状动脉综合征后的抑郁症：综述
Rev Cardiovasc Med. 2023 Sep 5;24(9):247. doi: 10.31083/j.rcm2409247. eCollection 2023 Sep.
10
Methionine sulfoxide reductase B2 protects against cardiac complications in diabetes mellitus.甲硫氨酸亚砜还原酶B2可预防糖尿病的心脏并发症。
Diabetol Metab Syndr. 2024 Jul 5;16(1):149. doi: 10.1186/s13098-024-01390-0.